Gracell Biotechnologies (NASDAQ: GRCL)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Gracell Biotechnologies (NASDAQ: GRCL) through any online brokerage.
The latest price target for Gracell Biotechnologies (NASDAQ: GRCL) was reported by Cantor Fitzgerald on Wednesday, June 1, 2022. The analyst firm set a price target for 20.00 expecting GRCL to rise to within 12 months (a possible 300.80% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Gracell Biotechnologies (NASDAQ: GRCL) is $4.99 last updated June 24, 2022, 8:00 PM UTC.
There are no upcoming dividends for Gracell Biotechnologies.
Gracell Biotechnologies’s Q2 earnings are confirmed for Tuesday, August 16, 2022.
There is no upcoming split for Gracell Biotechnologies.
Gracell Biotechnologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.